| Pharmaceutical Information |
| Drug Name |
Lisuride |
| Drug ID |
BADD_D01301 |
| Description |
An ergot derivative that acts as an agonist at dopamine D2 receptors (dopamine agonists). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (serotonin agonists). |
| Indications and Usage |
For the management of Parkinson's Disease |
| Marketing Status |
approved; investigational |
| ATC Code |
G02CB02; N02CA07 |
| DrugBank ID |
DB00589
|
| KEGG ID |
D08132
|
| MeSH ID |
D008090
|
| PubChem ID |
28864
|
| TTD Drug ID |
D0X7KB
|
| NDC Product Code |
Not Available |
| UNII |
E0QN3D755O
|
| Synonyms |
Lisuride | Lysurid | Methylergol Carbamide | Carbamide, Methylergol | Arolac | Cuvalit | Dopergine | Dopergin | Revanil | Lisuride, (8alpha)-(+-)-Isomer | Lysenyl | Lisuride Maleate | Maleate, Lisuride | Lysuride Hydrogen Maleate | Hydrogen Maleate, Lysuride | Lisuride Maleate (1:1) | Lisuride Maleate, (8beta)-Isomer | Lisuride Mesylate | Mesylate, Lisuride | Lisuride Phosphate (1:1) | Lisuride Hydrochloride | Hydrochloride, Lisuride |
|
| Chemical Information |
| Molecular Formula |
C20H26N4O |
| CAS Registry Number |
18016-80-3 |
| SMILES |
CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Gambling disorder | 19.07.06.015 | - | - | - |
|
|
|
